ERBB2 and familial pancreatic carcinoma: Thus, VPA treatment simultaneously down-regulates expression of EGFR, ErbB2, and ErbB3 in the ErbB family members-coexpressing pancreatic cancer cells, which in turn results in induction of cell growth inhibition as well as apoptosis.